explore -WSS

explore

author：Wikipedia 2025-09-14 21:56:21 - browse：1

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Methadone doses haven’t kept up in the age of fentanyl

Wikipedia

WSS

The best solution to the drug shortages problem

Philips to halt sales of sleep apnea machines in U.S.

White House pharmacy plagued with problems, investigation finds

A biotech analyst on neuroscience, placebo effect, not over

Syphilis numbers in the United States reach record heights

Wegovy trial has doctors encouraged over new possibilities

hotspot

explore

explore

In Memoriam: Notable people who died in 2023

Boston competes with Raleigh

United colonoscopy coverage change 'may cost lives,' doctors say

Zyn nicotine pouches become unlikely player in latest culture war

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Vertex non

Cancer drug shortages should be causing more outrage

Why you shouldn’t ask, “What country has the best health care?”

23andMe had bad news about my health. I wish a person had delivered it

Syphilis numbers in the United States reach record heights

hotspot

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

Vertex non

Humana’s losses in Medicare Advantage tank its stock

What to know about Virgin Galactic's 1st mission taking paying customers to space

The best solution to the drug shortages problem

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Wikipedia

Wikipedia

hotspot

hotspot